We are live on
!
Find out more
MAM
MPM Asset Management Portfolio holdings
AUM
$44.5M
1-Year Est. Return
47.28%
This Fund
S&P 500
This Quarter
Est. Return
+20.77%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$204M
AUM Growth
+$16.8M
(+9%)
Cap. Flow
-$412K
Cap. Flow
% of AUM
-0.2%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ADAP
Adaptimmune Therapeutics
ADAP
|
+$412K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
WCPI
BAM
WAMC
NLVP
CIEP
IPI
CC
VSAM
MPM Asset Management's Q4 2023 Portfolio in Review
As of Q4 2023, MPM Asset Management held 7 positions worth $204M, up 9% from $187M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 7-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- MPM Asset Management's biggest Q4 2023 reduction was Adaptimmune Therapeutics, cutting an estimated $412K.
- MPM Asset Management's ten largest holdings make up 100% of its $204M portfolio in Q4 2023.
- MPM Asset Management opened 0 new positions and closed 0 in Q4 2023.
- MPM Asset Management's portfolio value rose 9% quarter-over-quarter to $204M.
Based on MPM Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.